Sun Pharma to acquire Organon for Inorganic Growth - The Financial World
Sun Pharma→Organon
May 1, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
United Surgical Partners International has completed the acquisition of ASCs (seven acquired), a ambulatory surgery business in Texas, for $125 million. The Dallas-based ASC operator expands outpatient surgical capacity and supports higher-acuity procedures, including robotic surgery programs, across its Texas footprint. USPI acquisitions add scale to its ambulatory surgery acquisition strategy and strengthen joint replacement and other specialty service lines. The healthcare M&A deal is an add on acquisition by a strategic buyer, with the seven acquired ASCs positioned to drive double-digit growth.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Sun Pharma→Organon
May 1, 2026
Vireo Growth→Fluent
May 1, 2026
Volaris Group→Interplayers
Apr 30, 2026
Tenet Healthcare→United Surgical Partners International
Apr 30, 2026
Vitalist→Somatix
Apr 30, 2026